Mario Nicolini

848 total citations
20 papers, 277 citations indexed

About

Mario Nicolini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Mario Nicolini has authored 20 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in Mario Nicolini's work include Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). Mario Nicolini is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). Mario Nicolini collaborates with scholars based in Italy, Poland and France. Mario Nicolini's co-authors include Paolo Zatta, E. Pasquini, Alberto Ravaioli, Lorenzo Gianni, Pier Paolo Fattori, Ilaria Panzini, Giovanni William Oliverio, Alessandra Ravaioli, F. Desiderio and Enrico Aitini and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The Oncologist.

In The Last Decade

Mario Nicolini

19 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Nicolini Italy 10 134 115 52 37 25 20 277
Abdesslam Chajara France 9 166 1.2× 245 2.1× 99 1.9× 30 0.8× 14 0.6× 14 430
Penny Powers United States 6 152 1.1× 49 0.4× 72 1.4× 80 2.2× 14 0.6× 13 372
Laura López-González Spain 10 58 0.4× 36 0.3× 116 2.2× 51 1.4× 12 0.5× 37 324
Ge Guan China 10 68 0.5× 59 0.5× 81 1.6× 57 1.5× 6 0.2× 27 298
Masato Itoh Japan 12 86 0.6× 112 1.0× 115 2.2× 15 0.4× 14 0.6× 31 418
Liang Chang China 11 66 0.5× 44 0.4× 121 2.3× 52 1.4× 7 0.3× 18 333
Ye Shen China 9 48 0.4× 48 0.4× 106 2.0× 34 0.9× 17 0.7× 33 367
Murat Koçer Türkiye 11 148 1.1× 74 0.6× 40 0.8× 40 1.1× 3 0.1× 33 250
Andrea De Censi Italy 10 186 1.4× 34 0.3× 150 2.9× 62 1.7× 7 0.3× 39 349
Xiaoxue Wang China 9 45 0.3× 23 0.2× 107 2.1× 46 1.2× 22 0.9× 31 293

Countries citing papers authored by Mario Nicolini

Since Specialization
Citations

This map shows the geographic impact of Mario Nicolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Nicolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Nicolini more than expected).

Fields of papers citing papers by Mario Nicolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Nicolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Nicolini. The network helps show where Mario Nicolini may publish in the future.

Co-authorship network of co-authors of Mario Nicolini

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Nicolini. A scholar is included among the top collaborators of Mario Nicolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Nicolini. Mario Nicolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pietri, Elisabetta, Ilaria Massa, Sara Bravaccini, et al.. (2018). Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. The Oncologist. 24(6). 743–e205. 8 indexed citations
2.
Dazzi, Claudio, Alessandro Gamboni, Angelo Delmonte, et al.. (2017). Randomized cross-over study of patient preference for oral or intravenous vinorelbine in the treatment of advanced NSCLC: A phase IV study.. Journal of Clinical Oncology. 35(15_suppl). e20676–e20676.
3.
Cazzaniga, Marina Elena, Laura Cortesi, Laura Scaltriti, et al.. (2017). Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?. International Journal of Breast Cancer. 2017. 1–6. 12 indexed citations
4.
Cazzaniga, Marina Elena, Laura Cortesi, Laura Scaltriti, et al.. (2016). Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study. Breast Cancer Research and Treatment. 160(3). 501–509. 43 indexed citations
5.
Fabbri, Paolo, Fabrizio Drudi, Emiliano Tamburini, et al.. (2016). Chemotherapy in metastatic hormone-naïve prostate cancer: Pooled analysis of randomized clinical trials.. Journal of Clinical Oncology. 34(2_suppl). 259–259. 1 indexed citations
6.
7.
Gianni, Lorenzo, et al.. (2010). Lipoplatin Treatment in Lung and Breast Cancer. PubMed. 2011. 1–7. 35 indexed citations
8.
Tamburini, Emiliano, Maximilian Papi, E. Pasquini, et al.. (2006). Palliative treatment with gefitinib (G) in advanced and heavy pre-treated non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 17139–17139. 1 indexed citations
9.
Papi, Maximilian, Giovenzio Genestreti, Davide Tassinari, et al.. (2006). 203 Pemetrexed in combination with carboplatin for the treatment of patients with malignant mesothelioma. Lung Cancer. 54. S49–S49. 1 indexed citations
10.
Santoro, Antonio, Elena Mancini, Cristina Robaudo, et al.. (2005). Online Convective Therapies: Results from a Hemofiltration Trial. Contributions to nephrology. 149. 51–57. 5 indexed citations
11.
Papi, Maximilian, Giovenzio Genestreti, Davide Tassinari, et al.. (2005). Malignant Pericardial Mesothelioma. Report of two Cases, Review of the Literature and Differential Diagnosis. Tumori Journal. 91(3). 276–279. 27 indexed citations
12.
Ravaioli, Alberto, M. Marangolo, E. Pasquini, et al.. (2002). Bolus Fluorouracil and Leucovorin With Oxaliplatin as First-Line Treatment in Metastatic Colorectal Cancer. Journal of Clinical Oncology. 20(10). 2545–2550. 32 indexed citations
13.
Filosa, Giorgio, Leonardo Bugatti, Mario Nicolini, & Roberto Verdolini. (2001). Calciphylaxis in two patients with end‐stage renal disease. Journal of the European Academy of Dermatology and Venereology. 15(5). 461–464. 2 indexed citations
14.
Pasquini, E., Paolo Rinaldi, Mario Nicolini, et al.. (2000). Breast involvement in immunolymphoproliferative disorders: Report of two cases of multiple myeloma of the breast. Annals of Oncology. 11(10). 1353–1360. 9 indexed citations
15.
Ravaioli, Alessandra, Debora Canuti, Lorenzo Gianni, et al.. (1997). Prognostic factors in hereditary and sporadic breast cancers: analysis of an Italian series of 602 patients. The Breast. 6(5). 275–280. 2 indexed citations
16.
Panzini, Ilaria, Giovanni William Oliverio, E. Pasquini, et al.. (1997). Vinorelbine Chemotherapy in Non Small Cell Lung Cancer: Experience in Elderly Patients. Journal of Chemotherapy. 9(4). 304–308. 22 indexed citations
17.
Pasquini, E., Lorenzo Gianni, Enrico Aitini, et al.. (1995). Acute Disseminated Intravascular Coagulation Syndrome in Cancer Patients. Oncology. 52(6). 505–508. 46 indexed citations
18.
Zatta, Paolo & Mario Nicolini. (1995). Non-Neuronal Cells in Alzheimer's Disease. WORLD SCIENTIFIC eBooks. 11 indexed citations
19.
Pasquini, E., Mario Nicolini, Giovanni Rosti, et al.. (1994). Prognostic Factors and Survival in Non-Hodgkin's Lymphomas: The Experience of the Istituto Oncologico Romagnolo (IOR). Leukemia & lymphoma. 14(5-6). 475–482. 1 indexed citations
20.
Zatta, Paolo & Mario Nicolini. (1993). Alzheimer's Disease and Related Disorders. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdesslam Chajara Breakdown of academic impact, for papers by Penny Powers Breakdown of academic impact, for papers by Laura López-González Breakdown of academic impact, for papers by Ge Guan Breakdown of academic impact, for papers by Masato Itoh Breakdown of academic impact, for papers by Liang Chang Breakdown of academic impact, for papers by Ye Shen Breakdown of academic impact, for papers by Murat Koçer Breakdown of academic impact, for papers by Andrea De Censi Breakdown of academic impact, for papers by Xiaoxue Wang
Rankless by CCL
2026